- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Waltham Today
By the People, for the People
Thermo Fisher Scientific Expands Global Biobank Leadership
Collaboration with PRECISE-SG100K Singapore to Advance Population-Scale Proteomics
Apr. 9, 2026 at 4:42pm
Got story updates? Submit your updates here. ›
A groundbreaking collaboration in population-scale proteomics aims to unlock new insights into disease and health through the analysis of 100,000 individual protein profiles.Waltham TodayThermo Fisher Scientific, a leading provider of scientific instruments and laboratory equipment, has announced a strategic collaboration with Precision Health Research, Singapore (PRECISE) to advance the PRECISE-SG100K project, which aims to conduct population-scale proteomics research.
Why it matters
This collaboration represents a significant step forward in the field of population-scale proteomics, which has the potential to revolutionize our understanding of disease and health. By leveraging Thermo Fisher's expertise in scientific instrumentation and PRECISE's access to a large-scale biobank, the project could lead to groundbreaking discoveries that improve disease prevention, diagnosis, and treatment.
The details
Through the collaboration, Thermo Fisher Scientific will provide advanced mass spectrometry and other analytical technologies to support the PRECISE-SG100K project, which aims to analyze the proteins of 100,000 Singaporean individuals. The data generated from this large-scale proteomics study will be used to better understand the relationship between proteins and various health conditions, potentially leading to new biomarkers and therapeutic targets.
- The strategic collaboration was announced on April 9, 2026.
The players
Thermo Fisher Scientific Inc.
A leading provider of scientific instruments and laboratory equipment, and the world leader in serving science.
Precision Health Research, Singapore (PRECISE)
A research organization in Singapore that is leading the PRECISE-SG100K project, a large-scale population proteomics study.
The takeaway
This collaboration between Thermo Fisher Scientific and PRECISE-SG100K represents a significant advancement in the field of population-scale proteomics, which has the potential to revolutionize our understanding of disease and lead to new breakthroughs in disease prevention, diagnosis, and treatment.


